AlphaFold predicted structure
UNC13A · Q9UPW8

Mean pLDDT
73.1/ 100
Confident
1,703 residues
Confidence breakdown
- Very high(≥ 90)35%
- Confident(70–90)34%
- Low(50–70)7%
- Very low(< 50)25%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
unc-13 homolog A
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
BOTH monoallelic and biallelic, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BOTH monoallelic and biallelic, autosomal or pseudoautosomalIntellectual disability
BOTH monoallelic and biallelic, autosomal or pseudoautosomalCongenital myaesthenic syndrome
BIALLELIC, autosomal or pseudoautosomalAdult onset neurodegenerative disorder
UnknownAmyotrophic lateral sclerosis/motor neuron disease
Unknownamyotrophic lateral sclerosis
neurodegenerative disease
complex neurodevelopmental disorder
monogenic diabetes
neurodevelopmental disorder
cerebellar ataxia
Tremor
cardiovascular disorder
Delayed speech and language development
Developmental regression
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Protein unc-13 homolog A
Plays a role in vesicle maturation during exocytosis as a target of the diacylglycerol second messenger pathway. Involved in neurotransmitter release by acting in synaptic vesicle priming prior to vesicle fusion and participates in the activity-dependent refilling of readily releasable vesicle pool (RRP). Essential for synaptic vesicle maturation in most excitatory/glutamatergic but not inhibitory/GABA-mediated synapses. Facilitates neuronal dense core vesicles fusion as well as controls the location and efficiency of their synaptic release (By similarity). Also involved in secretory granule priming in insulin secretion. Plays a role in dendrite formation by melanocytes (PubMed:23999003)
UNC13A · Q9UPW8

Mean pLDDT
73.1/ 100
Confident
1,703 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0